List of Contributors
Nabil Ahmed(Houston Methodist), Kamille A. West(National Institutes of Health Clinical Center), Michael A. Pulsipher(Primary Children's Hospital), Sujith K. Joseph(Baylor College of Medicine), Juliane Gust(University of Washington), Terry J. Fry(University of Colorado Anschutz Medical Campus), Rimas J. Orentas(Capital Caring), Francesco Ceppi(University of Lausanne), Craig A. Portell(University of Virginia), Nirali N. Shah(National Institutes of Health), Jacob Appelbaum(National Cancer Institute), Karlo Perica(Memorial Sloan Kettering Cancer Center), Agne Taraseviciute(Seattle Children's Hospital), Karen K. Ballen(University of Virginia Health System), Kris M. Mahadeo(Duke University), Khaled Sanber(University College London), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Krishna V. Komanduri(University of Miami), Indumathy Varadarajan(University of Virginia), Corinne Summers(Seattle Children's Hospital), Victor M. Orellana‐Noia(University of Virginia), Haneen Shalabi(Center for Cancer Research), David F. Stroncek(Yale University), Daniel W. Lee(University of Virginia Cancer Center), Rebecca Gardner(Seattle Children's Hospital), Alan S. Wayne(University of Southern California), Navin Pinto(Seattle Children's Hospital), Elad Jacoby(Edmond and Lily Safra Children's Hospital), Francesco Paolo Tambaro(The University of Texas MD Anderson Cancer Center), Cameron J. Turtle(The University of Sydney), Eoghan Molloy(National Institutes of Health Clinical Center), Kenneth Cornetta(Indiana University – Purdue University Indianapolis), Ping Jin(Yunnan University), Cristina Gutiérrez(The University of Texas MD Anderson Cancer Center), Jae H. Park(Memorial Sloan Kettering Cancer Center), Cathy Conry Cantilena(National Institutes of Health Clinical Center), Sandhya R. Panch(University of Washington), Tamila L. Kindwall‐Keller(MetroHealth Medical Center), Steven L. Highfill(National Institutes of Health)
Cited by 0
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k